EU Regulators’ Expectations for a Stem Cell Based Product Development
A Focus on CMC and NC Development

Executive Director, Voisin Consulting Life Sciences, France

Anne Dupraz-Poiseau is Executive Director at Voisin Consulting Life Sciences, France. She
has a global strategic role focused on the design and implementation of innovative regulatory
strategies for cell based and tissue engineered products, medical devices (including in-vitro
diagnostics), drug/device combination and borderline products.

Anne manages
multidisciplinary teams dedicated to complex and innovative healthcare product development
programs, including for personalized medicine.

Prior to joining Voisin Consulting, Anne co-founded the regulatory consulting firm Meditest
International, based in Rennes, France. She began her career as Research & Development
Project Manager for Medtronic Sofamor-Danek.
Anne earned her “European” Ph.D. degree jointly from the University of Dental Surgery in
Nantes, France, the Free University of Berlin, Germany and the University of Medicine of Leiden,
Netherlands, working on the development and evaluation of combination products aimed at bone
substitution. Anne is a member of the Board of Editors of the SCRIP Regulatory Affairs Journal.